VARICELLA ZOSTER VIRUS INFECTION
Clinical trials for VARICELLA ZOSTER VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new VARICELLA ZOSTER VIRUS INFECTION trials appear
Sign up with your email to follow new studies for VARICELLA ZOSTER VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a vaccine shield transplant patients from shingles?
Knowledge-focused OngoingThis study looks at how the immune system of kidney transplant patients responds to the shingles vaccine and to natural shingles infection. Researchers will track antibody and T-cell levels over time in patients who have had a transplant or are on the waiting list. The goal is to…
Matched conditions: VARICELLA ZOSTER VIRUS INFECTION
Sponsor: Susanne Dam Nielsen, MD, DMSc • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Can immune cells predict herpesvirus danger in transplant patients?
Knowledge-focused OngoingThis study looks at how the immune system's T cells respond to two common herpesviruses—cytomegalovirus (CMV) and varicella-zoster virus (VZV)—in people who have had a liver transplant. Because transplant recipients take drugs that suppress their immune system to prevent organ re…
Matched conditions: VARICELLA ZOSTER VIRUS INFECTION
Sponsor: Susanne Dam Nielsen, MD, DMSc • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Shingrix vaccine study probes skin immunity in young and old
Knowledge-focused OngoingThis study looks at how the Shingrix vaccine, which protects against shingles, affects immune cells in the skin and blood. Researchers will give the vaccine to 50 healthy adults in two age groups: 30-40 years old and 70 years or older. They will measure specific antibodies and T-…
Matched conditions: VARICELLA ZOSTER VIRUS INFECTION
Phase: PHASE4 • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC